In the six months since its initial launch, GPC-USA has already made tremendous progress, launching its first two consortia on oncology and endocrine/metabolic diseases. The Oncology Consortium will be led by Donna Messner, while the Metabolic and Endocrine Consortium will be led by C. Daniel Mullins. GPC-USA is a multi-stakeholder forum that is developing condition-specific study design recommendations to guide the generation of evidence needed to inform coverage and payment decisions in the United States. Read here for more information. (Source: Green Park Collaborative, Summer 2013).
You are here: / / GPC-USA’s New Consortia in Oncology and Metabolic Diseases